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Nickel is the most common metal allergen and predominantly affects women. It is also the 
ubiquitous component in the alloys used to manufactre intracranial devices for aneurysm 
treatments, including aneurysm clips, self-expanding stents, flow-diverting stents and 
endosaccular occlusion devices. Adverse events related to nickel-allergy after deployment of 
such devices are uncommon but can be severe, resulting in dilemmas in the choice of treatment 
strategies and devices in managing nickel-sensitive pati nts with intracranial aneurysms. 
 
Methods: 
A literature search in accordance with the PRISMA guidelines was performed to identify studies 
reporting on nickel-related adverse events in cerebral aneurysm treatment. The material of the 
culprit devices, clinical presentation, histological feature and treatment were reviewed. The 
clinical consideration and management options for nickel allergy patients were discussed. 
 
Results: 
Nickel is a major component of the cobalt-alloy used in aneurysm clips, and of nitinol which is 
commonly used in flow-diverters and intracranial stents. There were 9 papers reporting 10 
unique cases of nickel-related adverse events after n urysm treatment. Half of the cases 













Two presented with dermatological and 8 with neurological manifestations including cerebral 
edema and cerebritis.  
 
Conclusions: 
Neurological complication related to nickel in cerebral aneurysm treatments is rare but remains a 
concern due to the high prevalence of nickel allergy in the population. Surgeons and 
interventionists should consider the metal-allergy history and its potential clinical significance in 















 Nickel allergy affects approximately 10-15% of thepopulation with it more common in 
women.1 It is the most common allergen identified on skin patch testing, and is associated with a 
history of ear piercing.2,3 While most presented as contact dermatitis, other manifestations in the 
gastrointestinal, respiratory and neurological systems are possible after intake of nickel-rich food, 
referred to as the systemic nickel allergy syndrome.4 Nickel-containing alloys have become 
ubiquitous in the manufacturing of modern neurovascular medical devices due to its memory and 
flexibility. In the treatment of cerebral aneurysms in particular, aneurysm clips, endovascular 
devices and stents including the new developed flow-diverting devices are made of a varying 
proportion of nickel.  
 Allergic reactions to nickel had been implicated in complications related to coronary 
stents, causing migraine headaches and in-stent stenosis. In addition, systemic allergic responses 
such as fever, dyspnea, generalized dermatitis and pericarditis after endovascular treatment with 
nickel-containing stent-grafts or implants have been reported.5 In order to familiarize surgeons 
and interventionists with the clinical significance of this under-recognized but potentially 
consequential nickel allergy in the management of cerebral aneurysms, we reviewed the 
literature on the composition of commonly used neuros gical and neurointerventional devices, 
and the complications related to nickel allergy in the setting of cerebral aneurysm treatment.  
 
Material Methods 













 The nickel content of common devices used in aneurysm treatment was identified from 
the product specifications or through medical devic approval bodies. The manufacturers of 
these devices were contacted to confirm the nickel ontent of specific devices when such 
information was not available in the literature. 
We performed a systematic search in the English literature with Ovid Medline, Pubmed, 
and Embase from 1960 to January 2018. The following terms and their combinations are used as 
keywords or MeSH terms: nickel, nitinol, stainless steel, allergy, hypersensitivity, aneurysms, 
cerebral aneurysm, clips, stent, coil, endovascular, embolization, clipping, reconstruction and 
adverse effects. We also searched the references of r levant articles to identify additional studies 
pertaining to nickel-related adverse events that were not included in the initial literature search.  
Studies reporting confirmed or probable nickel-related adverse events after cerebral 
aneurysm treatment were included. Exclusion criteria were: (1) cases with adverse events due to 
materials or metals other than nickel, (2) cases where nickel-related adverse events occurred after 
treatment of extracranial vascular pathologies such as peripheral artery or coronary artery disease. 
 
Outcome variables 
 The offending device, material, clinical presentation and treatment outcome of cases with 
nickel-related adverse events were extracted from the included studies. The results of skin patch 















 The initial literature search yielded 494 studies. After an initial screening of the title and 
abstract to exclude irrelevant papers, 38 studies were assessed for eligibility. Of these, 14 papers 
containing descriptions of unique patients presented with adverse events after cerebral aneurysm 
treatment were evaluated with the inclusion and exclusion criteria. 2 studies reporting non-nickel 
metal allergies and 3 studies with adverse events attributed to the non-metallic coating of coils 
were eliminated, leaving 9 studies to be included in the final analysis.6-14 The PRISMA process 
was presented in Figure 1. 
All the included studies were case reports or serie. In one study that reported 2 patients 
with adverse events after endovascular treatment of cerebral aneurysms, one patient was proven 
to be non-reactive to nickel with skin patch test and was excluded, leaving a total of 10 unique 
patients in the review. 
 
Nickel content in common neurosurgical and neurointervention devices 
Aneurysm clips 
 Modern aneurysm clips currently available are either made of cobalt-alloys or titanium-
alloys. Phynox, Elgiloy, and MP35N are 3 common cobalt-alloys used in the Yarsagil FE, Sugita 
and Slim-line (including Sundt clips) aneurysm clips, respectively. Phynox and Elgiloy contain 
14-16% nickel, and MP35N contained 35% nickel.  
Newer iterations of the common aneurysm clip system are available with titanium-alloy 
since the mid-1990s. These clips are made with Ti6Al4V alloys which comprised of over 89% 














Endovascular aneurysm devices 
The detachable coils were all nickel-free. Other common devices used in aneurysm 
treatment such as all intracranial self-expanding stent  were made of nitinol, as were the 
endosaccular occlusion devices (WEB, Luna), and selected flow-diverters (SILK, FRED, P64). 
The main component of Pipeline embolization device was another nickel-alloy 35NLT, which 
comprised of 33-37% nickel. Surpass were made of a c b lt- chromium alloy and contained the 
lowest nickel content of 14-16% amongst flow-diverters. (Table 1) 
 
Nickel-related complications after aneurysm treatment 
All 10 patients identified were female, and the median age was 47.8 years old (range 33-
64). Half had nickel-related adverse events after an urysm clipping, and the remaining occurred 
after endovascular treatments. The clinical characte istics, offending device, adverse events, skin 
patch test results, histological findings and clinial course of the patients were detailed in Table 2. 
The diagnostic certainly of the nickel-related allergic response were classified as “probable” or 
“highly likely” if they fulfilled one or both of the following criteria:  1) histological prove of 
















Ross et al. described the first nickel allergy reaction after aneurysm clipping with a 
Phynox clip, which contained 14-16% nickel. His patient developed generalized pruritis and a 
papular rash one month after clipping, with skin patch test confirming nickel reaction. The 
cutaneous symptoms resolved after the Phynox clip was exchanged for a titanium clip in a 
second craniotomy.10 More recently, scalp erythema with localized alopecia attributed to allergic 
reaction to the nickel-containing 316 stainless steel h ad pins was reported in a patient after 




Loco-regional cerebritis and cerebral edema were the predominant presentation of nickel 
allergy in the central nervous system. There were 8 such cases that occurred after cerebral 
aneurysm treatment with nickel-containing devices.  In the 3 cases where cerebral reactions 
occur after clipping with nickel-containing clips, the patients presented 10 days to 2 months after 
the craniotomy with cerebral edema as the common radiological feature.6,10,11,13 Neurological 
symptoms ranged from cerebral infarction and seizur to benign headache. Permanent deficits 
occurred in 2 patients. All underwent a second craniotomy with biopsy samples taken adjacent to 
the nickel-containing aneurysm clip showing histological evidence of cerebritis and vasculitis 
such as perivascular lymphocytic aggregation, compatible with delayed hypersentivity reaction. 
They were treated with systemic steroid and the offnding aneurysm clips were exchanged to 













 Following endovascular treatment, there were 4 reports including 5 patients where 
adverse cerebral reactions related to nickel allergy were identified.7,9,12,14 The reactions were 
attributed to intracranial stents and flow-diverter made of nitinol (55% nickel) in 4 patients, and 
to the nitinol guidewire used in the procedure in 1patient. Similar to the clipping-related cases, 
the majority of these patients presented in a subacutely within the first month after coiling of the 
aneurysm. Diffuse cerebral edema with seizure or focal neurological deficits related to the 
involved territory was the main clinical presentation, resulting in hemiparesis, visual disturbance 
and brainstem pseudobulbar palsy. They were treated medically with systemic high dose 
methylprednisolone followed by a course of prednisolone, and all had radiological resolution of 
the cerebral edema and symptomatic improvement. 
 
Discussion 
Nickel use in aneurysm treatment devices 
Nickel is commonly alloyed to use in the production of medical devices and implants for 
its ductility, strength profile and biocompatibility. Nickel-containing stainless steel can be made 
without ferromagnetism to allow for MRI compatibility, favouring its use in devices used in the 
treatment of neurovascular diseases such as aneurysms where MRI is frequently used for 
diagnosis and subsequent surveillance. The first documented aneurysm clip used was made of 
silver.15 Since then, the predominant material had evolved to stainless steel for the stronger 
spring action in 1950s, and subsequently to cobalt alloys for its superior tissue compatibility 
since the 1980s. While most stainless steel clips made from ferromagnetic 301 or 304 stainless 













Elgiloy and MP35N remain widely used. Newer iterations of the common aneurysm clip systems 
are available with nickel-free titanium-alloy since the mid-1990s. However, cobalt alloy clips are 
unlikely to be completely replaced as they afford a stronger spring action and clamping force.16 
The armamentarium of endovascular aneurysm treatment consisted of coils, flow-
diverters, endosaccular occlusion devices, and in selected cases stents and bifurcation devices. 
Apart from the detachable coils which were all nickel-free, the majority of the other devices were 
made with nickel-containing alloys such as nitinol. Nickel is the major component of nitinol, 
accounting for 55% by weight with the rest being titan um. The main advantage of nitinol is the 
shape-memory, which is instrumental in self-expanding stents and devices. 
 
Spectrum and clinical course of nickel-related complications 
Given the 10-15% prevalence of nickel allergy in the population1, the reported incidence 
of nickel-related adverse events after aneurysm treatm nt was remarkably low, and only 10 cases 
were identified in the literature.  These reactions may well be under-diagnosed, especially when 
many could be sub-clinical and reversible. All the reported nickel-related adverse reactions 
occurred in female patients, with either dermatological or neurological manifestations.  
Allergic skin reactions after implantation of nickel-containing device have been reported 
after orthopaedic implants, coronary stenting, implantation of patent foramen ovale occluders 
and cardiac pacemakers, as well as stenting for peripheral vascular disease and aortic aneurysm 
repair.5,17-19 Those patients typically presented with generalized rash and varying degree of 
systemic allergic response such as fever or respiratory difficulties within days after device 













devices were extremely rare and only 2 cases were id ntified.8,10 One presented as generalized 
rash secondary to a Phynox aneurysm clip, and the other as alopecia after local contact with 
nickel-containing head pins.  In contrast, the neurological complications including cerebritis and 
cerebral edema in 8 of the included patients were unique to intracranial aneurysm treatment and 
not reported in non-neurosurgical procedures involving nickel implants.  
 Apart from the nickel content, the amount of free nickel ion release after device 
implantation may be of critical importance, as systemic allergic response was initiated with the 
release of free nickel ions in the body.20 In an in vitro study using human endothelial cells, 
inflammatory markers were significantly up-regulated after incubation with nitinol wires with a 
higher release of free nickel ions, but not when incubated with low nickel release wires.21  
While there were no studies on the nickel release after neurysm clipping or stenting, 
Ries et al. studied the serum nickel concentration in 67 atrial septal defect patients before and 
after implantation of a nitinol foramen ovale occluder containing 55% nickel. 22  Compared with 
preoperative serum, the free nickel level increased significantly at 24 hours, peaked at 1 month, 
then gradually returned to baseline at 12 months after the nitinol occluder implantation. The 
temporal pattern of nickel concentration change corresponded to the 3 to 4-week latency of the 
adverse reactions occurring in the patients after treatment with nitinol intracranial stents in our 
review. Notably, Ries et al. demonstrated the marked individual variation in the nickel levels 
after implantation of the same device. This variabil ty may account for the difference in severity 
of symptoms and the lack of reactions in known nickel-sensitive patients treated with nitinol 
devices, as allergic reactions to nickel are known to display a clear dose-response relationship 
amongst nickel-sensitive persons.23  After nitinol devices were implanted, the release of nickel 













layer as shown in in-vitro bioenvironment, coupled with the effect of endothelialization of the 
nitinol stent.24 This could explain the radiological resolution of cerebral edema over time in 6 of 
the patients, even though the nickel-containing clip or stent was not removed. 
 
Treatment of nickel-related reactions 
Although mild contact dermatitis can be managed with topical steroid alone, removal of 
the offending implant should be considered in patients with systemic reaction to the nickel. Prior 
reports concerning stenting in peripheral vascular diseases reported prompt resolution of allergic 
response after the nitinol stent was removed with subsequent surgical reconstruction of the 
parent vessel.17 In the setting of implanted cerebrovascular devices, however, this can be both 
challenging and risky. For the 4 patients who develop d nickel reaction after aneurysm clipping, 
the aneurysm clips were removed and exchanged to titanium-made ones in 3 patients. The 
remaining patient developed severe scarring around the aneurysm clip, and microsurgical 
dissection and clip manipulation was deemed too risky.  
Contrary to the clipping cases, where the clip is extra-vascular, those who developed 
reaction after placement of an endovascular nitinol stent cannot have the implant endovascularly 
removed without excessive risk of vessel dissection and perforation. As previously noted, these 
patients tend to present weeks after the initial treatment, when endothelial remodelling may have 
partially incorporated the stents. In the reported cases, they were instead treated medically with 
systemic steroid and all had radiological and sympto atic resolution. Extracting the stent with 













serve as a last resort for medically-refractory patients, and had been performed in other scenarios 
such as migrated flow-diverters. 25,26  
 
Management considerations 
 Enquiring the patient for an allergy history to metal could be easily done preoperatively 
and would provide important information. Nickel-allergy should be suspected as a potential 
cause for unusual neurological or dermatological rections occurring in the first weeks after 
aneurysm treatment with nickel-containing devices, after ruling out vascular or infective 
complications. While histological samples would be th  gold standard for diagnosing 
immunologic response related to metal allergy, open biopsy may not be justified especially in 
endovasculary-treated patients and should be reservd when there was diagnostic difficulty.  
Allergy to nickel can also be readily confirmed with skin patch test in patients with known or 
suspected nickel allergy.27 Typically, 2.5% and 5% nickel sulphate solution were placed on a 
reservoir sheet epidermically, and the occurrence ad severity of local erythematous and papular 
reactions were assessed after 7 days. Other metal constituents of the contemplated device could 
also be tested, such as cobalt chloride and chromium tr chloride. Skin patch test using a reagent 
triturated from the endovascular device itself may be of value in establishing definitive diagnosis 
of allergic reactions secondary to the implantation. Uwatoko et al., identified a rare case of 
allergic reaction to platinum detachable coils after aneurysm coiling by performing skin patch 














 Development of aneurysm clips made of titanium had replaced the majority of stainless 
steel clips and effectively removed the risk of nickel reaction in aneurysm patients amenable to 
surgical clipping. In the rare case when patients wi h history of severe reactions to nickel 
required implantation of a nickel-containing device for aneurysm treatment (eg. a giant internal 
carotid artery aneurysm best treated with stent-assisted coiling or flow-diverter), nickel 
desensitization could be considered. This is performed with incremental oral dose of nickel, and 
had been shown in a randomized controlled trial to be effective in systemic nickel allergy 
syndrome.29 For patients presenting with a nickel-related reactions after aneurysm treatment, an 
initial course of systemic steroid should be considere . In the future, next-generation stents made 
of novel materials such as nickel-free alloys or polymers may be the solution.30   
 
Conclusion 
 While complication related to nickel in cerebral aneurysm treatments is rare, it remains a 
concern due to the high prevalence of nickel allergy in the population. Surgeons and 
interventionists should consider the metal-allergy history and its potential clinical significance in 
managing nickel-allergic patients with aneurysms. 
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Table 1. Nickel content in common devices for cerebrovascular diseases. 
Device Manufacturer Main Material Nickel content 
Aneurysm clips 
Yasargil Phynox Aesculap Phynox 14-16%  
AVM Microclips Aesculap Phynox 14-16% 
Sugita standard Mizuho Elgiloy 14-16% 
Sugita AVM clips Mizuho Elgiloy 14-16% 
Slim-line aneurysm clips  Codman MP 35N 35% 
Yarsargil Titanium Aesculap Titanium alloy ASTM 
F136 
0% 
Sugita T2 Mizuho Titanium alloy ASTM 
F136 
0% 
Perneczky aneurysm clips Adeor Titanium alloy ISO 
5832-3 
0% 
Self-expanding Stents/ Bifurcation devices 
Enterprise/ Enterprise 2 Codman Neuro Nitinol 55% 
LVIS MicroVention Nitinol 55% 
Neuroform EZ/ Neuroform 3 Stryker Nitinol 55% 
Wingspan Stryker Nitinol 55% 
PulseRider Pulsar Vascular Nitinol 55% 
pCONUS Phenox Nitinol 55% 
Leo+/ Leo+ baby Balt Nitinol 55% 
Carotid Wallstent Boston Scientific Elgiloy 14-16% 
Cerebral Coils (detachable component) 
Axium/ Axium Prime Medtronic Platinum 0% 




















MicroPlex Microvention Platinum 0% 
Target Stryker Platinum 0% 
GDC Stryker Platinum 0% 
Matrix2 Stryker Platinum, PGLA braid 0% 
Micrus Codman Neuro Platinum +/- cerecyte-
PGA 
0% 
Smart Coil Penumbra Platinum 0% 
Penumbra Coil 400 Penumbra Platinum 0% 
Flow-diverters 
Pipieline embolization device Medtronic 35N LT, Platinum 25%-28% 
SILK Balt Nitinol 55% 
FRED MicroVention Nitinol 55% 
Surpass Stryker Cobalt-chromium 
alloy, Platinum 
14-16% 
P64 Phenox Nitinol 55% 
Endosaccular occlusion device 
WEB Sequent Nitinol 55% 
Luna Covidien Nitinol 55% 
Stent Retreivers 
Solitaire Platinum/ Solitaire FR Medtronic Nitinol 55% 
Trevo XP / Trevo Stryker Nitinol 55% 
Catch plus Balt Nitinol 55% 
Head frame pins 
Sugita pins Mizuho 316L stainless steel 10-12% 














Table 2. Clinical characteristics, treatment and outcome of nickel-related adverse reactions after aneurysm treatment. 
 Age Location History of 
Metal 
allergy 






























































































Ono et al., 
20168 
45/F AcomA Metal 
jewellery 
Sugita headpins Alopecia, scalp 
erythema 
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- Nickel is ubiquitous in the devices used in cerebral aneurysm treatment 
- Although rare, dermatological and neurological complications including cerebral 
edema and cerebritis could occur after treatment with nickel-containing aneurysm 
clips or stents. 
- Most nickel-related adverse events could be managed with steroid therapy. 
- Clinicians should consider the metal allergy history in deciding the optimal 















AcomA: Anterior communicating artery 
ICA, Internal carotid artery 
MCA: Middle cerebral artery 
PcomA: Posterior communicating artery 
PRISMA:  Preferred Reporting Items for Systematic Reviews and Meta-Analyses  
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